Log In
BCIQ
Print this Print this
 

Vavelta (ICX-RHY)

  Manage Alerts
Collapse Summary General Information
Company Ember Therapeutics Inc.
DescriptionAllogeneic, collagen-secreting human dermal fibroblasts (HDFs) presented in a sterile suspension
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Organ/tissue engineering

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/16/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today